Combined effect of chronic kidney disease and peripheral arterial disease on all-cause mortality in a high-risk population

Clinical Journal of the American Society of Nephrology

Volumn 3, Issue 4, 2008, Pages 1084-1089

  Liew, Yin Ping ^a   Bartholomew, John R ^a   Demirjian, Sevag ^a   Michaels, Jeannie ^a   Schreiber Jr , Martin J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

AGED; ANKLE; ARTICLE; BLOOD; BLOOD PRESSURE; BRACHIAL ARTERY; CHRONIC DISEASE; COMPARATIVE STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HOSPITALIZATION; HUMAN; KAPLAN MEIER METHOD; KIDNEY DISEASE; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PERIPHERAL VASCULAR DISEASE; RETROSPECTIVE STUDY; RISK; RISK ASSESSMENT; TIME; VASCULARIZATION;

AGED; AGED, 80 AND OVER; ANKLE; BLOOD PRESSURE; BRACHIAL ARTERY; CHRONIC DISEASE; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY DISEASES; MALE; MIDDLE AGED; ODDS RATIO; PERIPHERAL VASCULAR DISEASES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 49149098480     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04411007     Document Type: Article

References (39)

1. Part 1. Executive summary to K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39: S1-S17, 2002
2. Selvin E, Erlinger TP: Prevalence of and risk factors for peripheral arterial disease in the united states: Results from the national health and nutrition examination survey, 1999-2000. Circulation 110: 738-743, 2004
3. Fried LF, Shlipak MG, Crump C, Bleyer AJ, Gottdiener JS, Kronmal RA, Kuller LH, Newman AB: Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol 41: 1364-1372, 2003
4. Ruilope LM, Salvetti A, Jamerson K, Hansson L, Warnold I, Wedel H, Zanchetti A: Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol 12: 218-225, 2001
5. Muntner P, He J, Hamm L, Loria C, Whelton PK: Renal insufficiency and subsequent death resulting from cardiovascular disease in the united states. J Am Soc Nephrol 13: 745-753, 2002
6. Shlipak MG, Fried LF, Stehman-Breen C, Siscovick D, Newman AB: Chronic renal insufficiency and cardiovascular events in the elderly: Findings from the cardiovascular health study. Am J Geriatr Cardiol 13: 81-90, 2004
7. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S: Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: The HOPE randon-dzed trial. Ann Intern Med 134: 629-636, 2001
8. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004
9. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ: Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies. J Am Soc Nephrol 15: 1307-1315, 2004
10. Stevens LA, Fares G, Fleming J, Martin D, Murthy K, Qiu J, Stark PC, Uhlig K, Van Lente F, Levey AS: Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: Evidence for lack of physician awareness of chronic kidney disease. J Am Soc Nephrol 16: 2439-2448, 2005
11. Tonelli M, Bohm C, Pandeya S, Gill J, Levin A, Kiberd BA: Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency. Am J Kidney Dis 37: 484-489, 2001
12. Wright RS, Reeder GS, Herzog CA, Albright RC, Williams BA, Dvorak DL, Miller WL, Murphy JG, Kopecky SL, Jaffe AS: Acute myocardial infarction and renal dysfunction: A high-risk combination. Ann Intern Med 137: 563-570, 2002
13. Shlipak MG, Heidenreich PA, Noguchi H, Chertow GM, Browner WS, McClellan MB: Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 13: 555-562, 2002
14. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR: Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 286: 1317-1324, 2001
15. McDermott MM, Mehta S, Ahn H, Greenland P: Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med 12: 209-215, 1997
16. Fowkes FG: The measurement of atherosclerotic peripheral arterial disease in epidemiological surveys. Int J Epidemiol 17: 248-254, 1988
17. Resnick HE, Lindsay RS, McDermott MM, Devereux RB, Jones KL, Fabsitz RR, Howard BV: Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: The strong heart study. Circulation 109: 733-739, 2004
18. Newman AB, Shemanski L, Manolio TA, Cushman M, Mittelmark M, Polak JF, Powe NR, Siscovick D: Ankle-arm index as a predictor of cardiovascular disease and mortality in the cardiovascular health study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol 19: 538-545, 1999
19. Newman AB, Sutton-Tyrrell K, Vogt MT, Kuller LH: Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. JAMA 270: 487-489, 1993
20. Newman AB, Tyrrell KS, Kuller LH: Mortality over four years in SHEP participants with a low ankle-arm index. J Am Geriatr Soc 45: 1472-1478, 1997
21. de Vinuesa SG, Ortega M, Martinez P, Goicoechea M, Campdera FG, Luno J: Subclinical peripheral arterial disease in patients with chronic kidney disease: Prevalence and related risk factors. Kidney Int Suppl S44-S47, 2005
22. O'Hare AM, Glidden DV, Fox CS, Hsu CY: High prevalence of peripheral arterial disease in persons with renal insufficiency: Results from the national health and nutrition examination survey 1999-2000. Circulation 109: 320-323, 2004
23. Mostaza JM, Suarez C, Manzano L, Cairols M, Garcia-Iglesias F, Sanchez-Alvarez J, Ampuero J, Godoy D, Rodriguez-Samaniego A, Sanchez-Zamorano MA, MERITO Study Group: Relationship between ankle-brachial index and chronic kidney disease in hypertensive patients with no known cardiovascular disease. J Am Soc Nephrol 17[Suppl 3]: S201-S205, 2006
24. Fishbane S, Youn S, Flaster E, Adam G, Maesaka JK: Ankle-arm blood pressure index as a predictor of mortality in hemodialysis patients. Am J Kidney Dis 27: 668-672, 1996
25. Eggers PW, Gohdes D, Pugh J: Nontraumatic lower extremity amputations in the Medicare end-stage renal disease population. Kidney Int 56: 1524-1533, 1999
26. O'Hare A, Johansen K: Lower-extremity peripheral arterial disease among patients with end-stage renal disease, Am Soc Nephrol 12: 2838-2847, 2001
27. Reddan DN, Marcus RJ, Owen WF Jr, Szczech LA, Land-wehr DM: Long-term outcomes of revascularization for peripheral vascular disease in end-stage renal disease patients. Am J Kidney Dis 38: 57-63, 2001
28. O'Hare AM, Bertenthal D, Shlipak MG, Sen S, Chren MM: Impact of renal insufficiency on mortality in advanced lower extremity peripheral arterial disease. J Am Soc Nephrol 16: 514 -519, 2005
29. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130: 461-470, 1999
30. O'Hare AM, Rodriguez RA, Bacchetti P: Low ankle-brachial index associated with rise in creatinine level over time: Results from the atherosclerosis risk in communities study. Arch Intern Med 165: 1481-1485, 2005
31. Shlipak MG, Fried LF, Crump C, Bleyer AJ Manolio TA, Tracy RP, Furberg CD, Psaty BM: Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 107: 87-92, 2003
32. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 97:425-428, 1998
33. Muntner P, Hamm LL, Kusek JW, Chen J, Whelton PK, He J: The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med 140: 9-17, 2004
34. Danesh J, Collins R, Peto R: Lipoprotein(a) and coronary heart disease: Meta-analysis of prospective studies. Circulation 102: 1082-1085, 2000
35. Malinow MR, Bostom AG, Krauss RM. Homocyst(e)ine, diet, and cardiovascular diseases: A statement for healthcare professionals from the nutrition committee, American Heart Association. Circulation 99: 178-182, 1999
36. Manns BJ, Burgess ED, Hyndman ME, Parsons HG, Schaefer JP, Scott-Douglas NW: Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease. Am J Kidney Dis 34: 669-677, 1999
37. Collins AJ, Li S, Gilbertson DT, Liu J, Chen SC, Herzog CA: Chronic kidney disease and cardiovascular disease in the Medicare population. Kidney Int Suppl S24-S31, 2003
38. Foley RN, Murray AM, Li S, Herzog CA, McBean AM, Eggers PW, Collihs AJ: Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 16: 489-495, 2005
39. Poggio ED, Wang X, Greene T, Van Lente F, Hall PM: Performance of the Modification of Diet in Renal Disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol 16: 459-466, 2005